AstraZeneca India names Naveen Krishna Yamarthi to lead Chennai centre
In short
AstraZeneca India has appointed Naveen Krishna Yamarthi to lead the next phase of GITC Chennai’s evolution. The reporting names him as the person taking charge of the centre.
This matters to AstraZeneca India and its Chennai operations because leadership is changing. The reporting does not say when he starts, who he replaces, or what changes he will make.
What the reporting says
AstraZeneca India has appointed Naveen Krishna Yamarthi to lead the next phase of GITC Chennai’s evolution, according to a publisher-supplied summary. The reporting names him as the new leader for the Chennai centre, but gives no start date, predecessor or specific mandate. What remains unclear is the scope of the role and any operational changes.
Why it matters
AstraZeneca India has appointed Naveen Krishna Yamarthi to lead the next phase of GITC Chennai’s evolution. The available summary identifies him as the new lead, but does not state the start date, the previous head or any specific operational goals. The immediate impact is on AstraZeneca India’s Chennai centre and its leadership structure.